Corona Research Limburg

Completed

• Conditions: Corona antibodies; SARS-CoV-2 antibodies; 10047438

• Registration Number: NL-OMON49431
• Lead Sponsor: GGD Zuid Limburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 10000

Inclusion Criteria

18 years or older
and capable to read the study information and fill in the questionnaire;
and willing to have their blood drawn for testing

Exclusion Criteria

younger than 18 years of age
insufficienly capable to understand the Dutch language
unwilling to have blood drawn for antibody testing

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome measure of the study is the result of SARS-CoV-2 antibody<br /><br>testing (positive or negative), based on total IgG (dichotomous value).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The IgG titre (continuous value).</p><br>